RDF of MGI data
表現型アノテーション
abnormal femur morphology_Galnt3<tm1Mjec>/Galnt3<tm1Mjec>
http://metadb.riken.jp/0000559I129SSvEvC57BL6JGalnt3tm1MjecGalnt3tm1MjecGalnt3tm1Mjec
abnormal femur morphology_Galnt3<tm1Mjec>/Galnt3<tm1Mjec>(表現型アノテーション)
ダウンロード
SPARQL
足あと
問い合わせ
URI表示モード
abnormal femur morphology_Galnt3<tm1Mjec>/Galnt3<tm1Mjec>
表現型アノテーション
MGI marker
http://metadb.riken.jp/db/mgi_rdf/variant_of
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3
http://metadb.riken.jp/db/mgi_rdf/MGI:894695
遺伝子型
http://metadb.riken.jp/db/mgi_rdf/allele_composition
Galnt3<tm1Mjec>/Galnt3<tm1Mjec>
アレルシンボル
http://metadb.riken.jp/db/mgi_rdf/allele_symbol
Galnt3<tm1Mjec>
遺伝的背景
http://metadb.riken.jp/db/mgi_rdf/genetic_background
involves: 129S/SvEv * C57BL/6J
MP annotation
http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype
abnormal femur morphology
http://purl.obolibrary.org/obo/MP_0000559
文献
http://purl.org/net/cito/citesAsAuthority
Shoji. Ichikawa, et.al., Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression., Endocrinology, 2009, 150
http://rdf.ncbi.nlm.nih.gov/pubmed/19213845
お問い合わせ
システムのお問い合わせ
画像
足跡